Clinical trial · Interventional
Lung Cancer Screening by Low Dose CT Scan in a French Department (DEP KP80)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Lung cancer is the leading cause of cancer death worldwide. The aims of this study were to assess the feasibility and effectiveness of a lung cancer screening pilot program with LD CT scan in a French department (Somme). DEP KP80 was a single-arm, prospective study started in May 2016. The inclusion criteria were those of the National Lung Screening Trial. An annual LD CT scan was scheduled and 2 rounds were planned. Smoking cessation was encouraged as part of the protocol. Subjects were selected by General Practitioner or Pneumologist who checked the inclusion criteria and prescribed the CT scan.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer Screening | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Low dose CT scan | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- screening
- description
- participants performed lung cancer screening by Low Dose CT scan
- interventionNames
- Other: Low dose CT scan
Primary outcomes (2)
- measure
- feasibility of lung cancer screening implementation in France: participation rate
- timeFrame
- 3 years
- description
- number of participants, participation rate : number of LD CT scan performed/ number of participants
- measure
- efficacity of lung cancer screening in France: number of lung cancer diagnosed, number of stage I, rate of surgery, rate of false positive
- timeFrame
- 3 years
- description
- number of lung cancer diagnosed, number of stage I, rate of surgery, rate of false positive
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 55 Years
- Maximum age
- 74 Years
Show eligibility criteria text
Inclusion Criteria: * male or female * smokers or former smoker, * aged between 55 and 74 * tobacco exposure of more than 30 pack-years, * active smokers or who quitted for less than 15 years, * obvious symptoms. Exclusion Criteria:criteria: * history of cancer within the last 5 years other than non melanoma skin cancer or carcinoma in situ, * worsening of their health state with Eastern Cooperative Oncology Group performance status\>3,- * heart or respiratory severe co-morbidity with contraindications to thoracoscopy
References
Publications (0)
Data not yet available